Assessment of BMS-986094-induced chronic cardiotoxicity using human iPS cell-derived cardiomyocytes

被引：0
|
作者：
Yanagida, Shota [1 ,2 ]
Satsuka, Ayano [1 ]
Hayashi, Sayo [1 ]
Ono, Atsushi [2 ]
Kanda, Yasunari [1 ]
机构：
[1] Natl Inst Hlth Sci, Div Pharmacol, Kawasaki, Kanagawa, Japan
[2] Okayama Univ, Graduated Sch Med Dent & Pharmaceut Sci, Div Pharmaceut Sci, Okayama, Okayama, Japan
来源：
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS | 2023年 / 123卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
SP104
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Chronic cardiotoxicity assessment of BMS-986094, a guanosine nucleotide analogue, using human iPS cell-derived cardiomyocytes
    Yanagida, Shota
    Satsuka, Ayano
    Hayashi, Sayo
    Ono, Atsushi
    Kanda, Yasunari
    JOURNAL OF TOXICOLOGICAL SCIENCES, 2021, 46 (08): : 359 - 369
  • [2] Cardiotoxicity evaluation of chronic BMS-986094 exposure in human iPSC-derived cardiomyocytes using a microelectrode array (MEA) assay
    Strock, Christopher J.
    Bradley, Jenifer
    Qin, Shuzhen
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2018, 93 : 129 - 129
  • [3] Drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes
    Yamazaki, Daiju
    Kitaguchi, Takashi
    Ishimura, Masakazu
    Taniguchi, Tomohiko
    Yamanishi, Atsuhiro
    Saji, Daisuke
    Takahashi, Etsushi
    Oguchi, Masao
    Moriyama, Yuta
    Maeda, Sanae
    Miyamoto, Kaori
    Morimura, Kaoru
    Ohnaka, Hiroki
    Tashibu, Hiroyuki
    Sekino, Yuko
    Miyamoto, Norimasa
    Kanda, Yasunari
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2018, 93 : 170 - 170
  • [4] Cardiotoxicity Assessment of Drugs Using Human iPS Cell-Derived Cardiomyocytes: Toward Proarrhythmic Risk and Cardio-Oncology
    Satsuka, Ayano
    Kanda, Yasunari
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2020, 21 (09) : 765 - 772
  • [5] Assessment of drug-induced QT prolongation using human iPS cell-derived mature cardiomyocytes
    Kanda, Yasunari
    Li, Min
    Ashihara, Takashi
    Sekino, Yuko
    Furukawa, Tetsushi
    Kurokawa, Junko
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2016, 81 : 384 - 384
  • [6] Usefulness of cardiotoxicity assessment using calcium transient in human induced pluripotent stem cell-derived cardiomyocytes
    Watanabe, Hitoshi
    Honda, Yayoi
    Deguchi, Jiro
    Yamada, Toru
    Bando, Kiyoko
    JOURNAL OF TOXICOLOGICAL SCIENCES, 2017, 42 (04): : 519 - 527
  • [7] Field potential measurement using iPS cell-derived cardiomyocytes for the prediction of cardiotoxicity in vitro
    Sakakibara, Mototsugu
    Kitamura, Tetsuo
    Otsuki, Makoto
    Bunai, Fumihide
    Minami, Daisuke
    Fujisaki, Yukiko
    Sekijima, Masaru
    Osada, Tomoharu
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2014, 70 (03) : 354 - 355
  • [8] A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes
    Ando, Hiroyuki
    Yoshinaga, Takashi
    Yamamotoa, Wataru
    Asakura, Keiichi
    Uda, Takaaki
    Taniguchi, Tomohiko
    Ojima, Atsuko
    Shinkyo, Raku
    Kikuchi, Kiyomi
    Osada, Tomoharu
    Hayashi, Seiji
    Kasai, Chieko
    Miyamotoa, Norimasa
    Tashibu, Hiroyuki
    Yamazaki, Daiju
    Sugiyama, Atsushi
    Kanda, Yasunari
    Sawada, Kohei
    Sekino, Yuko
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2017, 84 : 111 - 127
  • [9] Modeling Carfilzomib Induced Cardiotoxicity Using Human Induced Pluripotent Stem Cell-derived Cardiomyocytes
    Forghani, Parvin
    Rashid, Aysha
    Li, Dong
    Mandawat, Anant
    Xu, Chunhui
    CIRCULATION RESEARCH, 2020, 127
  • [10] Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)
    Narkar, Akshay
    Willard, James M.
    Blinova, Ksenia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
12345